PharmaCyte Biotech Inc (PMCB)

[bulldurham]

NOT TRUE...the best treatment wins out whether or not it was first...CiaB for Pancreatic Cancer beat Celgene's therapy from Austrianova's studies years ago...and yes Celgene's Abraxane got approval...(oh yeah and by Dr. Von Hoff) the same Von Hoff involved in our trials...

here is a good example...

http://www.pharmatimes.com/Article/14-09-09/NICE_no_for_Celgene_s_Abraxane_in_pancreatic_cancer.aspx

read the article...

"The National Institute for Health and Care Excellence has published new recommendations rejecting the use of Celgene’s Abraxane (nab-paclitaxel) on the National Health Service to treat patients with advanced pancreatic cancer."

"NICE says that data provided by Celgene show that the chemo regimen FOLFIRINOX, a first-line option for patients with the disease, was actually more clinically effective than the Abraxane/gemcitabine combination. And while Abraxane/gemcitabine was more effective than gemcitabine alone, it resulted in more serious side effects.

CiaB for Diabetes is completely different from the company you posted...
do some more DD on it...

bull